In fact, regulatory molecules governing early cell cycle progression such as cyclin D1-CDK4/6-Rb are the frequent targets of genetic alterations in an exceptionally high percentage of lung cancers [31]. This evidence concerns the gene CDK4 and lung carcinoma.